Cargando…
Stem cell therapy and tissue engineering for correction of congenital heart disease
This review article reports on the new field of stem cell therapy and tissue engineering and its potential on the management of congenital heart disease. To date, stem cell therapy has mainly focused on treatment of ischemic heart disease and heart failure, with initial indication of safety and mild...
Autores principales: | Avolio, Elisa, Caputo, Massimo, Madeddu, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485350/ https://www.ncbi.nlm.nih.gov/pubmed/26176009 http://dx.doi.org/10.3389/fcell.2015.00039 |
Ejemplares similares
-
Human Engineered Heart Tissue Models for Disease Modeling and Drug Discovery
por: Tani, Hidenori, et al.
Publicado: (2022) -
Recent advances and challenges on application of tissue engineering for treatment of congenital heart disease
por: Mantakaki, Antonia, et al.
Publicado: (2018) -
In Vitro and In Vivo Preclinical Testing of Pericyte‐Engineered Grafts for the Correction of Congenital Heart Defects
por: Alvino, Valeria Vincenza, et al.
Publicado: (2020) -
Decoding Genetics of Congenital Heart Disease Using Patient-Derived Induced Pluripotent Stem Cells (iPSCs)
por: Lin, Hui, et al.
Publicado: (2021) -
Editorial: Tissue Engineering and Cell Therapy for Cartilage Restoration
por: Fernandes, Tiago Lazzaretti, et al.
Publicado: (2022)